SPALLONE, VINCENZA
 Distribuzione geografica
Continente #
NA - Nord America 38.265
EU - Europa 3.935
AS - Asia 1.286
SA - Sud America 115
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 9
Totale 43.685
Nazione #
US - Stati Uniti d'America 38.122
IT - Italia 1.479
UA - Ucraina 545
DE - Germania 469
SG - Singapore 436
CN - Cina 366
IE - Irlanda 348
FR - Francia 308
KR - Corea 247
GB - Regno Unito 167
PL - Polonia 156
SE - Svezia 116
FI - Finlandia 104
MX - Messico 89
ES - Italia 55
RU - Federazione Russa 50
AU - Australia 46
IN - India 36
CA - Canada 35
CO - Colombia 28
JP - Giappone 26
VN - Vietnam 26
CH - Svizzera 22
KG - Kirghizistan 22
TR - Turchia 22
PE - Perù 21
NL - Olanda 20
BE - Belgio 18
CL - Cile 18
HK - Hong Kong 17
BR - Brasile 15
NZ - Nuova Zelanda 15
EC - Ecuador 14
HU - Ungheria 14
EU - Europa 12
IR - Iran 12
RO - Romania 12
DK - Danimarca 11
MY - Malesia 11
PH - Filippine 11
TH - Thailandia 11
ID - Indonesia 10
AR - Argentina 9
CZ - Repubblica Ceca 9
BG - Bulgaria 8
PK - Pakistan 8
BO - Bolivia 7
CR - Costa Rica 7
GR - Grecia 7
EG - Egitto 6
TW - Taiwan 6
GT - Guatemala 5
IQ - Iraq 4
AT - Austria 3
DO - Repubblica Dominicana 3
IL - Israele 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BD - Bangladesh 2
CM - Camerun 2
EE - Estonia 2
JO - Giordania 2
MD - Moldavia 2
ME - Montenegro 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
VE - Venezuela 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
HN - Honduras 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 43.685
Città #
Wilmington 11.061
Woodbridge 10.987
Houston 9.987
Fairfield 804
Chandler 724
Ann Arbor 586
Jacksonville 409
Ashburn 385
Singapore 368
Dublin 326
Seattle 276
Cambridge 265
Medford 246
Dearborn 215
Rome 189
Beijing 176
Kraków 153
New York 126
Lawrence 117
Redwood City 104
Santa Clara 82
Menlo Park 80
Milan 80
San Diego 51
Mülheim 38
Mountain View 33
Falls Church 32
Florence 30
Bologna 27
Zhengzhou 27
Boardman 26
Palo Alto 26
University Park 23
Bari 22
Moscow 22
Dong Ket 20
London 20
Verona 20
Kunming 19
Lima 19
Nanjing 18
Guangzhou 17
Naples 17
Padova 17
Barcelona 16
Santiago 15
Brussels 14
Kansas City 14
Norwalk 14
Palermo 14
Toronto 14
Budapest 13
Detroit 13
Bogotá 12
Dallas 12
Hefei 12
Hong Kong 12
Modena 12
Napoli 12
Hamilton 11
Helsinki 11
Nishi 11
Phoenix 11
Sydney 10
Trieste 10
Turin 10
Wuhan 10
Madrid 9
Mexico 9
Nürnberg 9
Veracruz 9
Zurich 9
Fuzhou 8
Melbourne 8
Ankara 7
Campegine 7
Creede 7
Genova 7
Jinan 7
Messina 7
Parma 7
Pisa 7
Redmond 7
Salerno 7
San Mateo 7
Vicenza 7
Honolulu 6
Indiana 6
La Paz 6
Lahaina 6
Munich 6
Perugia 6
Quito 6
Seoul 6
Torino 6
Washington 6
Amsterdam 5
Austin 5
Bangkok 5
Baotou 5
Totale 38.778
Nome #
Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes 1.044
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation 790
Neuropatia Diabetica 568
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 503
Neuropatia Diabetica 488
Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction? 476
Il trattamento della psoriasi nell’adulto. Linea guida 25. 458
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 457
Raccomandazioni sull’uso dei test cardiovascolari nella diagnosi di neuropatia autonomica diabetica 454
Diagnostic value of different autonomic symptoms assessed by COMPASS 31 for cardiovascular autonomic neuropathy and diabetic polyneuropathy 453
Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic 437
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 435
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 431
Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy 429
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 428
Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. 425
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 424
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 423
Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? 420
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 419
Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics 418
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 416
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 416
Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes 415
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 414
1965-2015, 1991-2015. 50 years of the EASD, 25 years of Neurodiab. Enduring friendship. A legacy for the future 410
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. 408
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 408
Neuropatia e assistenza al diabetico 407
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy 406
Twenty-four-hour pattern of blood pressure and spectral analysis of heart rate variability in diabetic patients with various degrees of autonomic neuropathy. Comparison to standard cardiovascular tests. 405
Diagnosis of cardiovascular autonomic neuropathy in diabetes 405
Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy 403
The relationship of autonomic neuropathy to other diabetic complications 402
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone 401
Combination Therapy in Diabetic Neuropathy 401
Effects of somatostatin on established induced ketosis 396
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 394
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 394
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 394
Psychopathology and dietary restriction: A comparison between eating disorders and Type 1 diabetes 393
Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes 392
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 392
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy 391
Benfotiamine: Commentary and update on recent studies 391
Might genetics play a role in understanding and treating diabetic polyneuropathy? 391
Perspectives in Diabetic Neuropathy: Update on Diagnostic Criteria and Treatment Options 391
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 390
Neuropathy in chronic kidney disease 390
Study of conduction velocity in diabetic with autonomic neuropathy. 389
Carbohydrate metabolism in hypertension: influence of treatment 384
Efficacy and safety of lacosamide in painful diabetic neuropathy 383
GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). 382
Autonomic neuropathy: Clinical and instrumental findings 377
Neuropatia diabetica autonomica, pressione arteriosa e funzione renale (Valsalva Lecture) 375
Prevenzione degli eventi avversi correlati alla presenza di complicanze del diabete (ipotensione ortostatica, danno renale acuto da mezzo di contrasto e ulcere da pressione) 375
Methods of investigation for cardiac autonomic dysfunction in human research studies 373
Management of painful diabetic neuropathy: guideline guidance or jungle? 373
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 370
Diabetic autonomic neuropathy 369
Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus 369
MicroRNA genetic variations: association with type 2 diabetes 369
Painful and painless diabetic neuropathy: one disease or two? 369
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 368
Neuropatia diabetica in Italia 367
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 366
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 364
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 364
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 364
Should we avoid the handgrip test in the assessment of cardiovascular autonomic neuropathy in diabetic patients? Exploratory factor analysis 364
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 363
Autonomic neuropathy and secondary hyperparathyroidism in uraemia 360
Reply to Circulating erythropoietin in diabetes mellitus. 359
Il corretto iter diagnostico della Neuropatia Diabetica 359
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 359
Improvement in peripheral and autonomic neuropathy during 18 months of treatment with subcutaneous continuous insulin infusion in type 1 diabetics 357
Relationship between hyperfunction of antral G cells (AGCH) and autonomic neuropathy (AN) in diabetic patients 357
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 353
Reappraisal of the diagnostic role of orthostatic hypotension in diabetes 351
Painful Diabetic Polyneuropathy: Approach to Diagnosis and Management 347
Le nuove frontiere della nutrizione. 344
Time for a Consensus Conference on pain in neurorehabilitation. 342
Costruire l'identità del nutrizionista 341
Why not to use the handgrip test in the assessment of cardiovascular autonomic neuropathy among patients with diabetes mellitus? 341
Microvascular complications in children and adolescents with type 1 diabetes 340
Impaired alpha cell function in conditions with cortisol deficiency 334
Disfunzione autonomica gastro-enterica e genito-urinaria 333
Screening e trattamento della neuropatia diabetica 333
Terapia farmacologica della neuropatia diabetica dolorosa 333
Novità in Endocrinologia. Calcificazione vascolare e osteolisi nella neuropatia diabetica - il legame mancante è il RANK-L? 332
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 332
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 331
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 329
Glycaemic control and gastric emptying 323
Position Statement sull’appropriatezza nella prescrizione degli esami di laboratorio in diabetologia 322
Comparative study of periferal and autonomic neuropathy in diabetes 321
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 315
The nerve axon reflex-vasodilation for the assessment of small nerve fibers' dysfunction in diabetic patients 308
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 307
Blood Pressure Variability and Autonomic Dysfunction 307
Totale 39.543
Categoria #
all - tutte 74.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.823 0 0 883 1.017 934 1.271 1.026 969 1.018 965 846 894
2020/20217.117 744 871 780 905 816 742 922 681 185 96 278 97
2021/20221.378 48 178 76 95 87 168 60 68 73 93 90 342
2022/20232.062 195 131 103 235 182 410 174 145 197 55 141 94
2023/20241.016 100 54 72 78 105 175 49 69 55 75 69 115
2024/2025800 135 664 1 0 0 0 0 0 0 0 0 0
Totale 44.133